Searching News Database: ACTIMMUNE
HSMN NewsFeed - 30 Mar 2015
Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per Share or $1.1 Billion in Cash
Horizon Pharma plc to Acquire Hyperion Therapeutics, Inc. for $46.00 per Share or $1.1 Billion in Cash
HSMN NewsFeed - 19 Mar 2014
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc
Horizon Pharma to Acquire Vidara Therapeutics International Ltd. and Become Horizon Pharma plc
HSMN NewsFeed - 14 Oct 2009
XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management
XOMA Appoints Susan Kramer, Dr. P.H. Vice President of Project and Alliance Management
HSMN NewsFeed - 15 May 2008
Proteolix Appoints Thomas Kassberg Executive Vice President of Corporate Development
Proteolix Appoints Thomas Kassberg Executive Vice President of Corporate Development
HSMN NewsFeed - 18 Mar 2008
Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
HSMN NewsFeed - 5 Mar 2007
InterMune Discontinues Phase 3 INSPIRE Trial of Actimmune in Idiopathic Pulmonary Fibrosis
InterMune Discontinues Phase 3 INSPIRE Trial of Actimmune in Idiopathic Pulmonary Fibrosis
HSMN NewsFeed - 18 Dec 2006
Aerovance Adds Accomplished Product Commercialization Executive to Leadership Team
Aerovance Adds Accomplished Product Commercialization Executive to Leadership Team
HSMN NewsFeed - 30 May 2006
Corgentech Announces Appointment of Susan Kramer as Vice President of Preclinical Development
Corgentech Announces Appointment of Susan Kramer as Vice President of Preclinical Development
Additional items found! 34
Members Archive contains
34 additional stories matching:
ACTIMMUNE
(Password required)
ACTIMMUNE
(Password required)